Ascending to new heights for novel therapeutics for eosinophilic esophagitis

- Hirano, Ikuo, Dellon, Evan S., Peterson, Kathryn, Talley, Nicholas J., Bierdermann, Luc, von Arnim, Ulrike, Savarino, Edoardo V., Schlag, Christoph, Wershil, Barry K., Menard-Katcher, Calies, Muir, Amanda B., Wechsler, Joshua B., Falk, Gary W., Chehade, Mirna, Spergel, JM, Atkins, D, Oliva, S, Arva, NC, Guang-Yu, Y, Jensen, ET, Safroneeva, E, Ackerman, S, Gupta, SK, Gonsalves, Nirmala P., Rothenberg, M, Katzka, D, Pletneva, M, Wright, BL, Hiremath, G, Klion, A, Attwood, S, Bonis, P, Aceves, S, Ghisa, M, Furuta, Glenn T., Miehlke, S, Vanuytsel, T, Woodland, G, Thomas, G, Kuang, FL, Bredenoord, Albert J., Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group,, Straumann, Alex, Schoepfer, Alain, Chang, Joy W.

Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)

- Ma, Christopher, Schoepfer, Alain M., Dellon, Evan S., Bredenoord, Albert J., Chehade, Mirna, Collins, Margaret H., Feagan, Brian G., Furuta, Glenn T., Gupta, Sandeep K., Hirano, Ikuo, Jairath, Vipul, Katzka, David A., Pai, Rish K., Rothenberg, Marc E., Straumann, Alex, Aceves, Seema S., Alexander, Jeffrey A., Arva, Nicoleta C., Atkins, Dan, Biedermann, Luc, Blanchard, C, Cianferoni, A, Ciriza de Los Rios, C, Clayton, F, Davis, CM, de Bortoli, N, Dias, JA, Falk, GW, Genta, RM, Ghaffari, G, Gonsalves, N, Greuter, T, Hopp, R, Hsu Blatman, KS, Jensen, ET, Johnston, D, Kagalwalla, AF, Larsson, HM, Leung, J, Louis, H, Masterson, JC, Menard-Katcher, C, Menard-Katcher, PA, Moawad, FJ, Muir, AB, Mukkada, VA, Penagini, R, Pesek, RD, Peterson, K, Putnam, PE, Ravelli, A, Savarino, EV, Schlag, C, Schreiner, P, Simon, D, Smyrk, TC, Spergel, JM, Taft, TH, Terreehorst, I, Vanuytsel, T, Venter, C, Vieira, MC, Vieth, M, Vlieg-Boerstra, B, von Arnim, U, Walker, Marjorie M., Wechsler, JB, Woodland, P, Woosley, JT, Yang, Guang-Yu, Zevit, N, Safroneeva, E